Split Fed. Circ. Backs PTAB Order Junking IPRs On Remand
The Patent Trial and Appeal Board's decision not to review a patent on the opioid addiction treatment Suboxone at all, after the Federal Circuit said the board didn't review enough of...To view the full article, register now.
Already a subscriber? Click here to view full article